GCAT (glycine C-acetyltransferase) is a pyridoxal phosphate-dependent enzyme that catalyzes the cleavage of 2-amino-3-oxobutanoate to glycine and acetyl-CoA, functioning in amino acid metabolism. The enzyme localizes to mitochondrial and nuclear compartments, suggesting roles in both energy metabolism and nuclear processes. However, the provided PubMed abstracts do not contain specific information about GCAT's disease relevance or clinical significance. The abstracts focus on genome-wide association studies identifying genetic variants associated with stroke, long COVID, severe COVID-19, and other conditions, but GCAT is not mentioned as a candidate gene in any of these analyses. Without abstracts specifically addressing GCAT function, mutation, or disease association, we cannot determine its clinical significance or disease relevance from the provided literature. Further investigation using abstracts specifically studying GCAT would be necessary to establish its role in human disease pathogenesis.